STOCK TITAN

[Form 4] Sysco Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Varonis Systems (VRNS) Form 4, filed 08/01/2025, reports a single insider transaction by director Fred Van den Bosch. On 08/01/2025 he sold 3,000 common shares at $55.08, generating proceeds of roughly $165k. The sale was executed under a Rule 10b5-1 trading plan, signalling it was pre-scheduled rather than discretionary.

After the transaction, Van den Bosch retains 128,666 shares of VRNS, indicating he disposed of only about 2.3 % of his direct holdings. No derivative security activity was reported. The filing does not include any other officers or material events, and it contains no earnings or guidance information. Given the modest size relative to his remaining stake and the pre-arranged nature, the sale is unlikely to materially affect the company’s fundamentals, but it does add a data point for investors monitoring insider sentiment.

Varonis Systems (VRNS) ha presentato il Modulo 4 il 01/08/2025, riportando una singola transazione interna da parte del direttore Fred Van den Bosch. In data 01/08/2025 ha venduto 3.000 azioni ordinarie a 55,08 $, generando proventi di circa 165.000 $. La vendita è stata eseguita nell'ambito di un piano di trading conforme alla Regola 10b5-1, indicando che era pre-programmata e non discrezionale.

Dopo la transazione, Van den Bosch detiene ancora 128.666 azioni di VRNS, il che indica che ha ceduto solo circa il 2,3% delle sue partecipazioni dirette. Non sono state riportate attività su strumenti derivati. Il documento non include altri dirigenti o eventi rilevanti, né informazioni su utili o previsioni. Considerata la dimensione modesta rispetto alla sua quota residua e la natura predefinita della vendita, è improbabile che influenzi materialmente i fondamentali della società, ma rappresenta comunque un dato utile per gli investitori che monitorano il sentiment interno.

Varonis Systems (VRNS) presentó el Formulario 4 el 01/08/2025, reportando una única transacción interna realizada por el director Fred Van den Bosch. El 01/08/2025 vendió 3,000 acciones ordinarias a $55.08, generando ingresos aproximados de $165,000. La venta se realizó bajo un plan de negociación conforme a la Regla 10b5-1, lo que indica que fue programada previamente y no discrecional.

Tras la transacción, Van den Bosch mantiene 128,666 acciones de VRNS, lo que indica que solo se deshizo de aproximadamente el 2.3% de sus participaciones directas. No se reportó actividad con valores derivados. El informe no incluye otros ejecutivos ni eventos materiales, ni contiene información sobre ganancias o previsiones. Dado el tamaño modesto en relación con su participación restante y la naturaleza preestablecida, es poco probable que la venta afecte materialmente los fundamentos de la empresa, aunque proporciona un dato relevante para los inversores que monitorean el sentimiento interno.

Varonis Systems(VRNS)는 2025년 8월 1일에 제출한 Form 4에서 이사 Fred Van den Bosch의 단일 내부 거래를 보고했습니다. 2025년 8월 1일 그는 3,000주 보통주를 주당 55.08달러에 매도하여 약 16만 5천 달러의 수익을 올렸습니다. 이 매도는 Rule 10b5-1 거래 계획에 따라 사전 예약된 거래였음을 나타냅니다.

거래 후 Van den Bosch는 VRNS 주식 128,666주를 보유하고 있어 직접 보유 지분의 약 2.3%만 처분한 셈입니다. 파생상품 관련 거래는 보고되지 않았습니다. 제출 서류에는 다른 임원이나 중요한 사건이 포함되어 있지 않으며, 수익이나 가이던스 정보도 없습니다. 남은 지분 대비 거래 규모가 크지 않고 사전 계획된 거래임을 고려할 때, 이번 매도는 회사의 기본적인 재무 상태에 큰 영향을 미치지 않을 가능성이 높습니다. 다만 내부자 심리를 관찰하는 투자자들에게는 참고할 만한 데이터 포인트가 됩니다.

Varonis Systems (VRNS) a déposé le formulaire 4 le 01/08/2025, rapportant une seule transaction d'initié effectuée par le directeur Fred Van den Bosch. Le 01/08/2025, il a vendu 3 000 actions ordinaires au prix de 55,08 $, générant un produit d'environ 165 000 $. La vente a été réalisée dans le cadre d'un plan de trading conforme à la règle 10b5-1, indiquant qu'elle était préprogrammée et non discrétionnaire.

Après la transaction, Van den Bosch détient toujours 128 666 actions de VRNS, ce qui signifie qu'il s'est uniquement séparé d'environ 2,3 % de ses participations directes. Aucune activité sur titres dérivés n'a été signalée. Le dépôt ne mentionne aucun autre dirigeant ni événement important, et ne contient aucune information sur les résultats ou les prévisions. Compte tenu de la taille modeste par rapport à sa participation restante et de la nature préétablie de la vente, il est peu probable que cette opération affecte significativement les fondamentaux de l'entreprise, mais elle constitue un point de donnée supplémentaire pour les investisseurs surveillant le sentiment des initiés.

Varonis Systems (VRNS) reichte am 01.08.2025 das Formular 4 ein, das eine einzelne Insider-Transaktion des Direktors Fred Van den Bosch meldet. Am 01.08.2025 verkaufte er 3.000 Stammaktien zu 55,08 $ und erzielte Erlöse von etwa 165.000 $. Der Verkauf erfolgte im Rahmen eines Rule 10b5-1 Handelsplans, was darauf hinweist, dass es sich um eine vorab geplante und nicht um eine diskretionäre Transaktion handelte.

Nach der Transaktion hält Van den Bosch weiterhin 128.666 VRNS-Aktien, was bedeutet, dass er nur etwa 2,3 % seiner direkten Beteiligungen veräußert hat. Es wurden keine Aktivitäten mit Derivaten gemeldet. Die Einreichung enthält keine weiteren Führungskräfte oder wesentliche Ereignisse und keine Angaben zu Gewinnen oder Prognosen. Angesichts der vergleichsweise geringen Größe im Verhältnis zu seinem verbleibenden Anteil und der vorab vereinbarten Natur ist es unwahrscheinlich, dass der Verkauf die Fundamentaldaten des Unternehmens wesentlich beeinflusst, liefert jedoch einen weiteren Datenpunkt für Investoren, die das Insider-Sentiment beobachten.

Positive
  • Sale executed under a Rule 10b5-1 plan, demonstrating adherence to trading best practices and reducing perception of opportunistic insider selling.
Negative
  • Director sold 3,000 shares, which some investors may interpret as a mild negative insider sentiment signal despite its small size.

Insights

TL;DR: Pre-planned 3k-share sale (~$165k) by VRNS director; negligible ownership change, neutral impact.

The transaction reduces Van den Bosch’s stake by just 2.3 %, leaving 128,666 shares, which limits signal value for valuation models. Because the sale was executed under a 10b5-1 plan and equals a fraction of average daily volume, I see minimal liquidity or sentiment impact. Insider activity trackers may record a slight uptick in sales, but fundamentals and consensus estimates remain unchanged.

TL;DR: 10b5-1 framework mitigates governance concern; transaction appears routine.

The use of an established 10b5-1 plan provides transparency and reduces litigation risk related to trading windows. No red flags such as clustered insider selling or executive departures accompany this filing. Oversight processes appear intact, keeping overall governance posture neutral.

Varonis Systems (VRNS) ha presentato il Modulo 4 il 01/08/2025, riportando una singola transazione interna da parte del direttore Fred Van den Bosch. In data 01/08/2025 ha venduto 3.000 azioni ordinarie a 55,08 $, generando proventi di circa 165.000 $. La vendita è stata eseguita nell'ambito di un piano di trading conforme alla Regola 10b5-1, indicando che era pre-programmata e non discrezionale.

Dopo la transazione, Van den Bosch detiene ancora 128.666 azioni di VRNS, il che indica che ha ceduto solo circa il 2,3% delle sue partecipazioni dirette. Non sono state riportate attività su strumenti derivati. Il documento non include altri dirigenti o eventi rilevanti, né informazioni su utili o previsioni. Considerata la dimensione modesta rispetto alla sua quota residua e la natura predefinita della vendita, è improbabile che influenzi materialmente i fondamentali della società, ma rappresenta comunque un dato utile per gli investitori che monitorano il sentiment interno.

Varonis Systems (VRNS) presentó el Formulario 4 el 01/08/2025, reportando una única transacción interna realizada por el director Fred Van den Bosch. El 01/08/2025 vendió 3,000 acciones ordinarias a $55.08, generando ingresos aproximados de $165,000. La venta se realizó bajo un plan de negociación conforme a la Regla 10b5-1, lo que indica que fue programada previamente y no discrecional.

Tras la transacción, Van den Bosch mantiene 128,666 acciones de VRNS, lo que indica que solo se deshizo de aproximadamente el 2.3% de sus participaciones directas. No se reportó actividad con valores derivados. El informe no incluye otros ejecutivos ni eventos materiales, ni contiene información sobre ganancias o previsiones. Dado el tamaño modesto en relación con su participación restante y la naturaleza preestablecida, es poco probable que la venta afecte materialmente los fundamentos de la empresa, aunque proporciona un dato relevante para los inversores que monitorean el sentimiento interno.

Varonis Systems(VRNS)는 2025년 8월 1일에 제출한 Form 4에서 이사 Fred Van den Bosch의 단일 내부 거래를 보고했습니다. 2025년 8월 1일 그는 3,000주 보통주를 주당 55.08달러에 매도하여 약 16만 5천 달러의 수익을 올렸습니다. 이 매도는 Rule 10b5-1 거래 계획에 따라 사전 예약된 거래였음을 나타냅니다.

거래 후 Van den Bosch는 VRNS 주식 128,666주를 보유하고 있어 직접 보유 지분의 약 2.3%만 처분한 셈입니다. 파생상품 관련 거래는 보고되지 않았습니다. 제출 서류에는 다른 임원이나 중요한 사건이 포함되어 있지 않으며, 수익이나 가이던스 정보도 없습니다. 남은 지분 대비 거래 규모가 크지 않고 사전 계획된 거래임을 고려할 때, 이번 매도는 회사의 기본적인 재무 상태에 큰 영향을 미치지 않을 가능성이 높습니다. 다만 내부자 심리를 관찰하는 투자자들에게는 참고할 만한 데이터 포인트가 됩니다.

Varonis Systems (VRNS) a déposé le formulaire 4 le 01/08/2025, rapportant une seule transaction d'initié effectuée par le directeur Fred Van den Bosch. Le 01/08/2025, il a vendu 3 000 actions ordinaires au prix de 55,08 $, générant un produit d'environ 165 000 $. La vente a été réalisée dans le cadre d'un plan de trading conforme à la règle 10b5-1, indiquant qu'elle était préprogrammée et non discrétionnaire.

Après la transaction, Van den Bosch détient toujours 128 666 actions de VRNS, ce qui signifie qu'il s'est uniquement séparé d'environ 2,3 % de ses participations directes. Aucune activité sur titres dérivés n'a été signalée. Le dépôt ne mentionne aucun autre dirigeant ni événement important, et ne contient aucune information sur les résultats ou les prévisions. Compte tenu de la taille modeste par rapport à sa participation restante et de la nature préétablie de la vente, il est peu probable que cette opération affecte significativement les fondamentaux de l'entreprise, mais elle constitue un point de donnée supplémentaire pour les investisseurs surveillant le sentiment des initiés.

Varonis Systems (VRNS) reichte am 01.08.2025 das Formular 4 ein, das eine einzelne Insider-Transaktion des Direktors Fred Van den Bosch meldet. Am 01.08.2025 verkaufte er 3.000 Stammaktien zu 55,08 $ und erzielte Erlöse von etwa 165.000 $. Der Verkauf erfolgte im Rahmen eines Rule 10b5-1 Handelsplans, was darauf hinweist, dass es sich um eine vorab geplante und nicht um eine diskretionäre Transaktion handelte.

Nach der Transaktion hält Van den Bosch weiterhin 128.666 VRNS-Aktien, was bedeutet, dass er nur etwa 2,3 % seiner direkten Beteiligungen veräußert hat. Es wurden keine Aktivitäten mit Derivaten gemeldet. Die Einreichung enthält keine weiteren Führungskräfte oder wesentliche Ereignisse und keine Angaben zu Gewinnen oder Prognosen. Angesichts der vergleichsweise geringen Größe im Verhältnis zu seinem verbleibenden Anteil und der vorab vereinbarten Natur ist es unwahrscheinlich, dass der Verkauf die Fundamentaldaten des Unternehmens wesentlich beeinflusst, liefert jedoch einen weiteren Datenpunkt für Investoren, die das Insider-Sentiment beobachten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gutierrez Victoria L

(Last) (First) (Middle)
1390 ENCLAVE PARKWAY

(Street)
HOUSTON TX 77077

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SYSCO CORP [ SYY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/31/2025 A 1,437.903(1) A $80.11 10,791.815 D
Common Stock 07/31/2025 F 351(2) D $80.11 10,440.815 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares received upon the vesting of performance share units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors (the "Committee") pursuant to the 2018 Omnibus Incentive Plan. These performance share units were granted by the Committee in August 2022. The number of shares of common stock received upon the vesting of these performance share units was determined based upon the Company's performance with regard to pre-established financial performance metrics for the performance period from fiscal 2023 to fiscal 2025.
2. These shares were withheld upon the vesting of performance share units to pay tax withholding obligations.
Remarks:
/s/Boyd Chapin, Attorney-in-Fact 08/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many VRNS shares did Fred Van den Bosch sell?

3,000 common shares were sold on 08/01/2025.

At what price were the VRNS shares sold?

The shares were sold at $55.08 per share.

How many VRNS shares does the director now own?

He owns 128,666 shares after the sale.

Was the transaction part of a 10b5-1 plan?

Yes, the filing states the sale was executed under a Rule 10b5-1 trading plan.

Does this filing indicate any change in insider status?

No; Van den Bosch remains a director with direct ownership of VRNS shares.
Sysco

NYSE:SYY

SYY Rankings

SYY Latest News

SYY Latest SEC Filings

SYY Stock Data

38.25B
483.80M
0.18%
89.58%
2.74%
Food Distribution
Wholesale-groceries & Related Products
Link
United States
HOUSTON